Nanobiotix S.A.
NBTX
$3.39
$0.24117.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -294.83% | -302.77% | 23.03% | 21.20% | 60.16% |
| Total Depreciation and Amortization | 7.12% | 9.28% | 4.61% | 7.10% | 7.05% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | -- | -- | 155.00% |
| Total Other Non-Cash Items | 158.04% | 163.23% | -32.60% | -30.99% | 0.29% |
| Change in Net Operating Assets | -52.49% | -51.53% | 113.26% | 118.32% | 376.18% |
| Cash from Operations | -382.97% | -388.66% | 66.60% | 65.80% | 125.82% |
| Capital Expenditure | -6,948.15% | -7,166.67% | -49.72% | -53.23% | 59.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -467.39% | -479.57% | -168.18% | -185.71% | -118.36% |
| Cash from Investing | -1,955.08% | -1,984.17% | -51.18% | -54.82% | -127.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.06% | -12.06% | -8.66% | -8.66% | -10.06% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.04% | 96.04% | -50.37% | -50.37% | -2,052.41% |
| Cash from Financing | -105.02% | -105.12% | -22.79% | -25.71% | 2,502.56% |
| Foreign Exchange rate Adjustments | 252.81% | 255.56% | 335.71% | 340.21% | -391.80% |
| Miscellaneous Cash Flow Adjustments | 0.00% | 20.00% | -- | -- | -- |
| Net Change in Cash | -130.63% | -131.25% | 55.22% | 54.16% | 361.33% |